LL-37 attenuates inflammatory impairment via mTOR signaling-dependent mitochondrial protection

Abstract

a b s t r a c tThe human cationic antimicrobial protein LL-37 is a multifunctional host defense peptide with a wide range of immunomodulatory activities. Previous work has shown that LL-37 exerts both pro-and antiinflammatory effects. The role of mitochondria in the skin inflammatory effects of LL-37 has not been well studied. Therefore, our aim was to investigate the immunomodulatory effect of LL-37 in HaCaT cells and to delineate the underlying mechanisms related to mitochondrial function. Immunohistochemistry results from tissue microarrays showed strong cytoplasmic LL-37 staining in inflammatory cells in chronic dermatic inflammation. Using exogenous LL-37 stimulation and LL-37 knockdown and overexpression, LL-37 was demonstrated to dramatically reduce the mRNA levels and protein secretion of inflammatory cytokines including IL-6, IL-8, IL-1␣ and tumor necrosis factor-␣ (TNF-␣), which are induced by lipopolysaccharides (LPS). The anti-inflammatory effects of LL-37 are dependent upon its ability to increase mitochondrial biogenesis and to maintain mitochondrial homeostasis. Furthermore, we observed that LL-37 enhances the LPS-induced phosphorylation of extracellular signal-regulated kinase (ERK1/2) and mammalian target of rapamycin (mTOR). The mTOR inhibitor rapamycin can neutralize the protective effects of LL-37 on mitochondria. In conclusion, these results suggest that high LL-37 expression levels correlate with chronic skin inflammation; mitochondrial dysfunction occurs in HaCaT cells during inflammation; and LL-37 attenuates inflammatory impairment by stimulating mitochondrial biogenesis and protecting mitochondrial function, which are dependent upon mTOR signaling. These findings provide new insights into targeting mitochondria with LL-37 to prevent skin inflammatory reactions.

Blood-cell bioenergetics are associated with physical function and inflammation in overweight/obese older adults

“…It is hypothesized that mitochondria may provide a robust indicator of bioenergetic crisis because they are sensitive to redox status (Bonnard et al, 2008), acute and chronic inflammation (Sun et al, 2014; Quoilin et al, 2014; Zapelini et al, 2008), and metabolic stress (Russell et al, 2002; Widlansky et al, 2010; Schulz et al, 2007), which are common features among many of the complex, chronic diseases associated with aging (Chacko et al, 2014; Kramer et al, 2014). Peripheral blood cells may recapitulate bioenergetic signatures found in skeletal muscle and other vascular tissues.…”

A Self-Healing Multifunctional Hydrogel System Accelerates Diabetic Wound Healing through Orchestrating Immunoinflammatory Microenvironment

“…IL-32-induced pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 were inhibited by LL-37 through activation of the phosphorylation of MKP-1 (S359), a negative regulator of inflammation. Moreover, LL-37 can also attenuate inflammatory impairment through stimulating mitochondrial biogenesis and protecting mitochondrial function, which are dependent on mTOR signaling …”

Integrative Analysis of Transcriptome-Wide Association Study and mRNA Expression Profiles Identified Candidate Genes and Pathways Associated With Acute Myocardial Infarction

“…Additionally, a previous study showed that inflammatory conditions or arginine catabolism could affect mitochondrial function (Lee and Huttemann, 2014;Tang et al, 2020). Sun et al indicated that the antiinflammatory effects of CAMP were dependent its ability to stimulate mitochondrial biogenesis and maintain mitochondrial homeostasis (Sun et al, 2014). Tang et al (2020) also found that the loss of ARG1 could cause arginine accumulation and mitochondrial dynamics disruption.…”